PsiloPharma_PI2RL_IINFACTS_2021 - Psilocybin as a new alternative for the treatment of depression: unraveling the pharmacology, toxicokinetics and impact on the rat microbiome

Principal Investigator: 
Diana Silva
Leader Institution: 
CESPU
Research Team: 
Diana Silva (PI), Áurea Carvalho (Co-PI), Andreia Costa, Nelson Mortágua, Sara Queirós
Funding entity: 
CESPU
Budget: 
9.000€
Period covered: 
22.03.2021 - 21.03.2022
Program: 
PI2RL_IINFACTS_2021